These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36086766)

  • 1. Integrated bioinformatics analysis reveals potential mechanisms associated with intestinal flora intervention in nonalcoholic fatty liver disease.
    Liu Y; Liu X; Zhou W; Zhang J; Wu J; Guo S; Jia S; Wang H; Li J; Tan Y
    Medicine (Baltimore); 2022 Sep; 101(36):e30184. PubMed ID: 36086766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bioinformatics screening and analysis of key differentially expressed genes characteristics in nonalcoholic fatty liver disease].
    Ding JX; Huang WB; Jiang XX; Zhang LD; Fang H; Jin J
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):297-303. PubMed ID: 35462486
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments.
    Wang J; Liu H; Xie G; Cai W; Xu J
    Mol Med Rep; 2020 Feb; 21(2):685-694. PubMed ID: 31974594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of the gut-liver axis to the immune signaling pathway of NAFLD.
    Liu J; Wu A; Cai J; She ZG; Li H
    Front Immunol; 2022; 13():968799. PubMed ID: 36119048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis.
    Mahmoudi A; Butler AE; Jamialahmadi T; Sahebkar A
    Biomed Res Int; 2021; 2021():3654660. PubMed ID: 34988225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial.
    Hui D; Liu L; Azami NLB; Song J; Huang Y; Xu W; Wu C; Xie D; Jiang Y; Bian Y; Sun M
    Front Endocrinol (Lausanne); 2022; 13():1107071. PubMed ID: 36743913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using bioinformatics and systems biology methods to identify the mechanism of interaction between COVID-19 and nonalcoholic fatty liver disease.
    Dong W; Jin Y; Shi H; Zhang X; Chen J; Jia H; Zhang Y
    Medicine (Baltimore); 2023 Jun; 102(23):e33912. PubMed ID: 37335656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network pharmacology analysis of Chaihu Lizhong Tang treating non-alcoholic fatty liver disease.
    Zhang M; Yuan Y; Zhou W; Qin Y; Xu K; Men J; Lin M
    Comput Biol Chem; 2020 Jun; 86():107248. PubMed ID: 32208163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between atherosclerosis and nonalcoholic fatty liver disease.
    Lv Q; Han Q; Wen Z; Pan Y; Chen J
    Medicine (Baltimore); 2024 Jan; 103(1):e36815. PubMed ID: 38181273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chin brick tea [Camellia sinensis (L.) Kuntze] on lipid metabolism and inflammation by modulating intestinal flora and bile acids in mice with non-alcoholic fatty liver disease.
    Jin C; Zhou T; Duan Z; Deng Y; Zhang X; Xiao C; He J; He G; Zhou Y; Li S
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116950. PubMed ID: 37506781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of the associations between non-alcoholic fatty liver disease and colorectal cancer.
    Qiu T; Hu W; Rao Z; Fang T
    Front Genet; 2022; 13():1007337. PubMed ID: 36568397
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of intestinal flora in the development of nonalcoholic fatty liver disease in children.
    Zhang J; Shi M; Zhao C; Liang G; Li C; Ge X; Pei C; Kong Y; Li D; Yang W; Cao B; Fu L; Yan Y; Wu J; Zhou J; Fang Y; Meng X; Li Y; Wang L
    Microbiol Spectr; 2024 Feb; 12(2):e0100623. PubMed ID: 38189294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics Analysis of Key Differentially Expressed Genes in Nonalcoholic Fatty Liver Disease Mice Models.
    Hou C; Feng W; Wei S; Wang Y; Xu X; Wei J; Ma Z; Du Y; Guo J; He Y; Kong F; Tang R; Zheng K
    Gene Expr; 2018 Dec; 19(1):25-35. PubMed ID: 30135001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of key genes in non‑alcoholic fatty liver disease progression based on bioinformatics analysis.
    Li L; Liu H; Hu X; Huang Y; Wang Y; He Y; Lei Q
    Mol Med Rep; 2018 Jun; 17(6):7708-7720. PubMed ID: 29620197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Differentially Expressed Genes and Signaling Pathways in Acute Myocardial Infarction Based on Integrated Bioinformatics Analysis.
    Chen DQ; Kong XS; Shen XB; Huang MZ; Zheng JP; Sun J; Xu SH
    Cardiovasc Ther; 2019; 2019():8490707. PubMed ID: 31772617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer.
    Zhang J; Zhang H; Li F; Song Z; Li Y; Zhao T
    BMC Med Genomics; 2020 Nov; 13(1):172. PubMed ID: 33198757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
    Kirpich IA; Marsano LS; McClain CJ
    Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A UPLC-Q-TOF/MS and network pharmacology method to explore the mechanism of Anhua fuzhuan tea intervention in nonalcoholic fatty liver disease.
    Tian FM; Yi J; Tang Y; Chen BW; Long HP; Liu YF; Ou-Yang Y; Zhang WJ; Tang RM; Liu BY
    Food Funct; 2023 Apr; 14(8):3686-3700. PubMed ID: 36971300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific changes of intestinal microflora in children with nonalcoholic fatty liver disease].
    Ling JR; Zhang YJ; Zhang ZH; He BH; Ni W; Shi WQ; Chen ZY
    Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):850-855. PubMed ID: 30392210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.